Filgotinib, Alfasigma’s candidate oral therapy for adults with active axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS), eased…
Lila Levinson, PhD
Lila is a Science Writer at Bionews. She completed her PhD in neuroscience at the University of Washington, where she studied how the natural flexibility of the human brain can be used to promote recovery after injury. Previously, she has written about science for The Dallas Morning News and the University of Washington Computational Neuroscience Center. She enjoys exploring the Pacific Northwest and spending time with her cat, Fibonacci.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lila Levinson, PhD
Higher levels of physical activity are linked to better disease outcomes and quality of life in people with axial spondyloarthritis…